Literature DB >> 23820984

Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Mak Adam Daulatzai1.   

Abstract

Late onset Alzheimer's disease (AD) is the most common cause of progressive cognitive dysfunction and dementia. Despite considerable progress in elucidating the molecular pathology of this disease, we are not yet close to unraveling its etiopathogenesis. The hippocampus is at the epicenter of cognition being associated with learning and memory. A battery of neurotoxic modifiers has been delineated that may unleash deleterious heterogeneous pathologic impacts. Synergistically they target hippocampus causing its neuronal degeneration, gray matter volume atrophy, and progressive cognitive decline. The neurotoxic factors include aging, stress, depression, hypoxia/hypoxemia, hypertension, diabetes, obesity, alcohol abuse, smoking, malnutrition, and polypharmacy-to name a few. Addressing "upstream pathologies" due to these multiple and heterogeneous neurotoxic modifiers vis-a-vis hippocampal dysfunction is of paramount importance. The downstream-generated inflammatory cytokines, mitochondrial dysfunction, oxidative stress, hypoperfusion, excitotoxicity, amyloid beta, and neurofibrillary tangles may then trigger and sustain neurocognitive pathology. The failure of clinical trials in AD is due in part to this complex multifactorial neurotoxic-pathophysiological labyrinth. The key is to employ appropriate preventive and treatment strategies prior to significant hippocampus damage and its dysfunction. Prevention/reversal of the diverse neurotoxic impacts, delineated here, should be an integral part of therapeutic armamentarium, in order to ameliorate hippocampus dysfunction and to enhance memory in aging, mild cognitive impairment, and AD. Throughout, the paper highlights both the challenges presented by the ever present neurotoxic onslaught, and the opportunities to overcome them. Hence, arresting AD pathogenesis is achievable through early intervention. A targeted approach may ameliorate neurocognitive pathology and attenuate memory deterioration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820984     DOI: 10.1007/s12640-013-9407-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  769 in total

1.  Cognitive aging and the hippocampus: how old rats represent new environments.

Authors:  Iain A Wilson; Sami Ikonen; Irina Gureviciene; Robert W McMahan; Michela Gallagher; Howard Eichenbaum; Heikki Tanila
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

2.  Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning.

Authors:  Ilana S Hairston; Milton T M Little; Michael D Scanlon; Monique T Barakat; Theo D Palmer; Robert M Sapolsky; H Craig Heller
Journal:  J Neurophysiol       Date:  2005-07-13       Impact factor: 2.714

3.  Tau, beta-amyloid and beta-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain.

Authors:  C Shukla; L R Bridges
Journal:  Neurosci Lett       Date:  2001-05-11       Impact factor: 3.046

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

Review 5.  Hippocampal granule cells in normal aging: insights from electrophysiological and functional imaging experiments.

Authors:  Monica K Chawla; Carol A Barnes
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

6.  Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

Authors:  Thomas Leyhe; Gerhard W Eschweiler; Elke Stransky; Thomas Gasser; Peter Annas; Hans Basun; Christoph Laske
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice.

Authors:  Aron M Troen; Melissa Shea-Budgell; Barbara Shukitt-Hale; Donald E Smith; Jacob Selhub; Irwin H Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

Review 8.  Amyloid beta peptides and glutamatergic synaptic dysregulation.

Authors:  Kodeeswaran Parameshwaran; Muralikrishnan Dhanasekaran; Vishnu Suppiramaniam
Journal:  Exp Neurol       Date:  2007-10-24       Impact factor: 5.330

9.  Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

Authors:  J Sastre-Garriga; G T Ingle; D T Chard; Lí Ramió-Torrentà; M A McLean; D H Miller; A J Thompson
Journal:  Arch Neurol       Date:  2005-04

10.  Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver.

Authors:  Darlan Pase da Rosa; Luiz Felipe Forgiarini; Diego Baronio; Cristiano Andrade Feijó; Dênis Martinez; Norma Possa Marroni
Journal:  Mediators Inflamm       Date:  2012-11-26       Impact factor: 4.711

View more
  23 in total

1.  The effect of polypharmacy on prefrontal cortex activation during single and dual task walking in community dwelling older adults.

Authors:  Claudene J George; Joe Verghese; Meltem Izzetoglu; Cuiling Wang; Roee Holtzer
Journal:  Pharmacol Res       Date:  2018-11-05       Impact factor: 7.658

Review 2.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

3.  Low-level laser therapy for beta amyloid toxicity in rat hippocampus.

Authors:  Yujiao Lu; Ruimin Wang; Yan Dong; Donovan Tucker; Ningjun Zhao; Md Ejaz Ahmed; Ling Zhu; Timon Cheng-Yi Liu; Robert M Cohen; Quanguang Zhang
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

4.  Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer's Disease.

Authors:  Mohammad Mahdi Ahmadian-Attari; Leila Dargahi; Mahmoud Mosaddegh; Mohammad Kamalinejad; Behzad Khallaghi; Fatemeh Noorbala; Abolhassan Ahmadiani
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

Review 5.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 6.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 7.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

Review 8.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

Review 9.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 10.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.